sfingolipidózy [Sphingolipidoses]

tematický
12
Termíny

Sphingolipid Storage Diseases
Sphingolipidosis

Perzistentní odkaz   https://www.medvik.cz/link/D013106
Definice

Jedná se o podskupinu lyzosomálních střádavých poruch, kdy se hromadí sfingolipidy v jednom nebo více orgánech jako důsledek primárního deficitu enzymu nebo jeho kofaktoru. (cit. WikiSkripta, 2018 http://www.wikiskripta.eu)

A group of inherited metabolic disorders characterized by the intralysosomal accumulation of SPHINGOLIPIDS primarily in the CENTRAL NERVOUS SYSTEM and to a variable degree in the visceral organs. They are classified by the enzyme defect in the degradation pathway and the substrate accumulation (or storage). Clinical features vary in subtypes but neurodegeneration is a common sign.

Anotace
general or unspecified; prefer specifics
obecné, dej přednost přesnějšímu deskriptoru
DUI
D013106 MeSH Prohlížeč
CUI
M0020298
Historická pozn.
1992(1974)
Veřejná pozn.
1992; see SPHINGOLIPIDOSIS 1974-91

C Nemoci
C10.228.140 nemoci mozku 1 177
C10.228.140.163 metabolické nemoci mozku 84
C10.228.140.163.100.435.295 fukosidóza 2
C10.228.140.163.100.435.340 glykogenóza typu II 59
C10.228.140.163.100.435.590 mukolipidózy 10
C10.228.140.163.100.435.810 nemoc z ukládání kyseliny sialové 3
C10.228.140.163.100.435.825 sfingolipidózy 12
C10.228.140.163.100.435.825.200 Fabryho nemoc 187
C10.228.140.163.100.435.825.250 Farberova nemoc 5
C10.228.140.163.100.435.825.300 gangliosidóza 11
C10.228.140.163.100.435.825.400 Gaucherova nemoc 83
C10.228.140.163.100.435.825.590 globoidní leukodystrofie 16
C10.228.140.163.100.435.825.700 Niemannova-Pickova nemoc 36
C10.228.140.163.100.435.825.775 syndrom histiocytů barvy mořské modři 4
C10.228.140.163.100.435.825.850 sulfatidóza 1
C16.320.565.189.435.295 fukosidóza 2
C16.320.565.189.435.340 glykogenóza typu II 59
C16.320.565.189.435.590 mukolipidózy 10
C16.320.565.189.435.810 nemoc z ukládání kyseliny sialové 3
C16.320.565.189.435.825 sfingolipidózy 12
C16.320.565.189.435.825.200 Fabryho nemoc 187
C16.320.565.189.435.825.250 Farberova nemoc 5
C16.320.565.189.435.825.300 gangliosidóza 11
C16.320.565.189.435.825.400 Gaucherova nemoc 83
C16.320.565.189.435.825.590 globoidní leukodystrofie 16
C16.320.565.189.435.825.700 Niemannova-Pickova nemoc 36
C16.320.565.189.435.825.775 syndrom histiocytů barvy mořské modři 4
C16.320.565.189.435.825.850 sulfatidóza 1
C16.320.565.398.641 lipidózy 35
C16.320.565.398.641.509 neuronální ceroidlipofuscinózy 29
C16.320.565.398.641.723 Sjögrenův-Larssonův syndrom 4
C16.320.565.398.641.803 sfingolipidózy 12
C16.320.565.398.641.803.300 Fabryho nemoc 187
C16.320.565.398.641.803.325 Farberova nemoc 5
C16.320.565.398.641.803.350 gangliosidóza 11
C16.320.565.398.641.803.441 Gaucherova nemoc 83
C16.320.565.398.641.803.585 globoidní leukodystrofie 16
C16.320.565.398.641.803.730 Niemannova-Pickova nemoc 36
C16.320.565.398.641.803.850 syndrom histiocytů barvy mořské modři 4
C16.320.565.398.641.803.925 sulfatidóza 1
C16.320.565.595.554.295 fukosidóza 2
C16.320.565.595.554.340 glykogenóza typu II 59
C16.320.565.595.554.590 mukolipidózy 10
C16.320.565.595.554.810 nemoc z ukládání kyseliny sialové 3
C16.320.565.595.554.825 sfingolipidózy 12
C16.320.565.595.554.825.200 Fabryho nemoc 187
C16.320.565.595.554.825.250 Farberova nemoc 5
C16.320.565.595.554.825.300 gangliosidóza 11
C16.320.565.595.554.825.400 Gaucherova nemoc 83
C16.320.565.595.554.825.590 globoidní leukodystrofie 16
C16.320.565.595.554.825.700 Niemannova-Pickova nemoc 36
C16.320.565.595.554.825.775 syndrom histiocytů barvy mořské modři 4
C16.320.565.595.554.825.850 sulfatidóza 1
C18.452 metabolické nemoci 1 196
C18.452.132.100.435.295 fukosidóza 2
C18.452.132.100.435.340 glykogenóza typu II 59
C18.452.132.100.435.590 mukolipidózy 10
C18.452.132.100.435.810 nemoc z ukládání kyseliny sialové 3
C18.452.132.100.435.825 sfingolipidózy 12
C18.452.132.100.435.825.200 Fabryho nemoc 187
C18.452.132.100.435.825.250 Farberova nemoc 5
C18.452.132.100.435.825.300 gangliosidóza 11
C18.452.132.100.435.825.400 Gaucherova nemoc 83
C18.452.132.100.435.825.590 globoidní leukodystrofie 16
C18.452.132.100.435.825.700 Niemannova-Pickova nemoc 36
C18.452.132.100.435.825.775 syndrom histiocytů barvy mořské modři 4
C18.452.132.100.435.825.850 sulfatidóza 1
C18.452.584.563.641 lipidózy 35
C18.452.584.563.641.509 neuronální ceroidlipofuscinózy 29
C18.452.584.563.641.723 Sjögrenův-Larssonův syndrom 4
C18.452.584.563.641.803 sfingolipidózy 12
C18.452.584.563.641.803.300 Fabryho nemoc 187
C18.452.584.563.641.803.325 Farberova nemoc 5
C18.452.584.563.641.803.350 gangliosidóza 11
C18.452.584.563.641.803.441 Gaucherova nemoc 83
C18.452.584.563.641.803.585 globoidní leukodystrofie 16
C18.452.584.563.641.803.730 Niemannova-Pickova nemoc 36
C18.452.584.563.641.803.850 syndrom histiocytů barvy mořské modři 4
C18.452.584.563.641.803.925 sulfatidóza 1
C18.452.648.189.435.295 fukosidóza 2
C18.452.648.189.435.340 glykogenóza typu II 59
C18.452.648.189.435.590 mukolipidózy 10
C18.452.648.189.435.810 nemoc z ukládání kyseliny sialové 3
C18.452.648.189.435.825 sfingolipidózy 12
C18.452.648.189.435.825.200 Fabryho nemoc 187
C18.452.648.189.435.825.250 Farberova nemoc 5
C18.452.648.189.435.825.300 gangliosidóza 11
C18.452.648.189.435.825.400 Gaucherova nemoc 83
C18.452.648.189.435.825.590 globoidní leukodystrofie 16
C18.452.648.189.435.825.700 Niemannova-Pickova nemoc 36
C18.452.648.189.435.825.775 syndrom histiocytů barvy mořské modři 4
C18.452.648.189.435.825.850 sulfatidóza 1
C18.452.648.398.641 lipidózy 35
C18.452.648.398.641.509 neuronální ceroidlipofuscinózy 29
C18.452.648.398.641.723 Sjögrenův-Larssonův syndrom 4
C18.452.648.398.641.803 sfingolipidózy 12
C18.452.648.398.641.803.300 Fabryho nemoc 187
C18.452.648.398.641.803.325 Farberova nemoc 5
C18.452.648.398.641.803.350 gangliosidóza 11
C18.452.648.398.641.803.441 Gaucherova nemoc 83
C18.452.648.398.641.803.585 globoidní leukodystrofie 16
C18.452.648.398.641.803.730 Niemannova-Pickova nemoc 36
C18.452.648.398.641.803.850 syndrom histiocytů barvy mořské modři 4
C18.452.648.398.641.803.925 sulfatidóza 1
C18.452.648.595.554.295 fukosidóza 2
C18.452.648.595.554.340 glykogenóza typu II 59
C18.452.648.595.554.590 mukolipidózy 10
C18.452.648.595.554.810 nemoc z ukládání kyseliny sialové 3
C18.452.648.595.554.825 sfingolipidózy 12
C18.452.648.595.554.825.200 Fabryho nemoc 187
C18.452.648.595.554.825.250 Farberova nemoc 5
C18.452.648.595.554.825.300 gangliosidóza 11
C18.452.648.595.554.825.400 Gaucherova nemoc 83
C18.452.648.595.554.825.590 globoidní leukodystrofie 16
C18.452.648.595.554.825.700 Niemannova-Pickova nemoc 36
C18.452.648.595.554.825.775 syndrom histiocytů barvy mořské modři 4
C18.452.648.595.554.825.850 sulfatidóza 1